Search concepts
|
Selected Filters
|
- 1,050 - 1,100 out of 1,362 results
Search results
-
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Chang, J. C., Darcourt, J., Geyer, C. E. & Niravath, P. A.
Project: Clinical Trial
-
Phase 3, Randomized, Open-Label Study to Compare Ociperlimab (BGB-A1217) Plus Tislelizumab (BGB-A317) Plus Concurrent Chemoradiotherapy (cCRT) Followed by Ociperlimab Plus Tislelizumab or Tislelizumab Plus cCRT Followed by Tislelizumab Versus cCRT Followed by Durvalumab in Previously Untreated, Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Bernicker, E. H., Singh, M. & Zhang, J.
Project: Clinical Trial
-
A PHASE 2 STUDY OF FUTIBATINIB IN PATIENTS WITH SPECIFIC FGFR ABERRATIONS
Abdelrahim, M., Heyne, K. & Singh, M.
Project: Clinical Trial
-
SH-REPAIR MR - Mitraclip Device vs. Surgical Repair for Mitral Regurgitation Abbott Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy Mitral Regurgitation who are Candidates for Surgery (REPAIR MR)
Goel, S., Bhimaraj, A., Faza, N., Guha, A., Kassi, M., Kleiman, N., Lawrie, G. M., Little, S. H., Reardon, M. J. & Yousefzai, R.
6/28/21 → …
Project: Clinical Trial
-
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Adjuvant Chemotherapy in High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy (RTOG 0724/GOG-0724 )
Kamat, A. A., Butler, E. B., Farach, A. M., Morgan, P. B., Shadle, K. M., Shkedy, C., Singh, M., Suri, A. & Zaid, T.
Project: Clinical Trial
-
-
REDUCE PAS
Lin, C. H., Chiu, D., Gadhia, R. R., Kleiman, N., Misra, V. & Volpi, J. J.
1/28/20 → …
Project: Clinical Trial
-
Neoadjuvant Atezolizumab in Patients With Non-Metastatic Resectable High-Risk Cutaneous Melanoma
Esnaola, N. F., Allenson, K. C., Bernicker, E. H., Chen, S. & Mohyuddin, N. G.
12/19/19 → …
Project: Clinical Trial
-
PSLOT_Radiocephalic Fistulas.
Peden, E. K., Le, L., Lumsden, A. B. & Rahimi, M.
8/12/20 → …
Project: Clinical Trial
-
-
-
EP-CATALYST - Amulet Device Compared to NOACs for A-Fib Treatment Abbott
Valderrábano, M., Dave, A., Goel, S., Lador, A., Mathuria, N. & Schurmann, P. A.
4/19/21 → …
Project: Clinical Trial
-
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared with Physician's Choice of Adjuvant Endocrine Monotherapy in Patients with Estrogen Receptor-Positive, Her2-Negative Early Breast Cancer
Chang, J. C. & Niravath, P. A.
11/21/22 → …
Project: Clinical Trial
-
SH-PORTICO NG
Kleiman, N., Faza, N., Gadhia, R. R., Garg, T., Goel, S., Little, S. H., Reardon, M. J. & Volpi, J. J.
7/8/20 → …
Project: Clinical Trial
-
Neuromuscular Observational Research (MOVR) Data Hub Protocol
Greene, E. P., Appel, S. H., Shroff, S. & Thonhoff, J. R.
5/17/19 → …
Project: Clinical Trial
-
Registry for Neurological Endpoint Assessments among patients with Ischemic and Hemorrhagic Stroke (REINAH)
Vahidy, F. S., Britz, G. W., Horner, P. J. & Misra, V.
4/28/20 → …
Project: Clinical Trial
-
Cephea Mitral Valve System for Treatment of MR EFS Abbott
Goel, S., Faza, N., Kleiman, N., Little, S. H., Reardon, M. J. & Yousefzai, R.
7/28/22 → …
Project: Clinical Trial
-
A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (VICTORION-2 PREVENT)
Volpi, J. J., Chang, S., Chiu, D., Gadhia, R. R., Garg, T. & Misra, V.
Project: Clinical Trial
-
-
HMDHVC Clinical CMR Database
Shah, D. J., El-Tallawi, C., Faza, N., Graviss, E. A., Lin, C. H. & Nabi, F.
Project: Clinical Trial
-
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry (IPF/ILD-PRO)
Safdar, Z., Huang, H. J. & Sahay, S.
8/2/18 → …
Project: Clinical Trial
-
-
MRI Guided PAD Imaging
Roy, T., Karmonik, C., Lumsden, A. B., Rivera, A. & Shah, D. J.
11/19/20 → …
Project: Clinical Trial
-
A Phase III, Open-Label, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab (Anti-PD-L1 Antibody) Compared With Best Supportive Care Following Adjuvant Cisplatin-Based Chemotherapy in Patients With Completely Resected Stage IB-IIIA
Bernicker, E. H., Heyne, K., Singh, M. & Zhang, J.
Project: Clinical Trial
-
Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer (INTEGRAL)
Chang, J. C., Niravath, P. A. & Venta, L. A.
10/31/22 → …
Project: Clinical Trial
-
Katherine, B50, for Treatment of Adjuvant HER2 Positive Breast Cancer
Chang, J. C., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
A Randomized, Open-label, Phase II Study of Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Subjects With Resectable Non-small Cell Lung Cancer (CANOPY-N)
Bernicker, E. H., Barrios, R., Chan, E. Y., Chang, J. C., Heyne, K., Kim, M. P., Niravath, P. A., Singh, M. & Zhang, J.
Project: Clinical Trial
-
-
Ocrelizumab for Psychosis by Autoimmunity (OPA)
Masdeu, J. C., Faridar, A., Nakawah, M. O., Pascual, B., Toledo, J. B. & Weinstein, B.
2/20/20 → …
Project: Clinical Trial
-
Higher neural changes in patients taking overactive bladder medications
Project: Clinical Trial
-
-
-
-
VAS-WRAPSODY Endovascular Stent Graft for Hemodialysis Patients Merit Medical
Peden, E. K., Le, L., Rahimi, M. & Roy, T.
7/30/21 → …
Project: Clinical Trial
-
X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP)
Project: Clinical Trial
-
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy as well as in Combination with TERN- 101 in Noncirrhotic Adults with Presumed Non-Alcoholic Steatohepatitis (NASH)
Victor, III, D. W. & Kodali, S.
1/18/23 → …
Project: Clinical Trial
-
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma who Have Received at Least 1 Prior Line of Therapy
Ganguly, S., Petkova, J., Pingali, S. R. & Shah, S.
Project: Clinical Trial